OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 69 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,160,097 | +247.4% | 93,935 | +154.0% | 0.00% | – |
| Q2 2023 | $333,974 | +135.3% | 36,985 | -9.6% | 0.00% | – |
| Q1 2023 | $141,906 | +81.0% | 40,895 | +27.8% | 0.00% | – |
| Q4 2022 | $78,383 | -85.0% | 31,993 | -83.1% | 0.00% | – |
| Q3 2022 | $522,000 | -37.5% | 189,009 | -7.9% | 0.00% | – |
| Q2 2022 | $835,000 | -56.0% | 205,297 | -54.0% | 0.00% | – |
| Q1 2022 | $1,899,000 | -6.7% | 445,948 | +104.9% | 0.00% | – |
| Q4 2021 | $2,036,000 | -51.0% | 217,600 | +44.5% | 0.00% | -100.0% |
| Q3 2021 | $4,151,000 | +202.1% | 150,619 | +206.7% | 0.00% | – |
| Q2 2021 | $1,374,000 | +96.3% | 49,112 | +132.7% | 0.00% | – |
| Q1 2021 | $700,000 | -73.6% | 21,101 | -61.7% | 0.00% | -100.0% |
| Q4 2020 | $2,652,000 | – | 55,165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |